John Lacy III - Dec 2, 2024 Form 4 Insider Report for PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)

Role
Director
Signature
/s/ John Lacey, III
Stock symbol
PVCT
Transactions as of
Dec 2, 2024
Transactions value $
$0
Form type
4
Date filed
12/4/2024, 09:49 PM
Previous filing
Sep 30, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PVCT Stock Options (Right to Buy) Award $0 +775K $0.00 775K Dec 2, 2024 Common Stock 775K $0.29 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.